Crysta IVF, one of India’s most trusted fertility chains, co- founded by Harshita Jain and Dheeraj Jain in 2018 together with healthcare institutional investors has recently appointed Dr. Neeta Jain as Head in Clinic Operations. In her role, she will be responsible to drive the complete operational strategy of the IVF business to increase operational efficiency and revenue. With her vast areas of expertise spanning across Business Development, Strategic Alliances, Implementation of Best Practices, Patient Counseling & Onboarding, Dr. Neeta Jain will spearhead clinic operations with a key impetus on strategy and streamlining of processes.
Holding a Masters degree in Genetics along with a PHD in biochemistry, Dr. Jain brings with herself over 25 years of experience working with various companies operating in the IVF space. She has been associated for over two decades with organizations such as World Infertility & IVF Centre and Medicover Fertility in roles related to business development, operations, patient counseling, and overall operations. She has been instrumental in ensuring that appropriate training is provided to IVF professionals so that they are able to serve their patients more efficiently.
Commenting on the appointment, Dheeraj Jain, Founder, Crysta IVF, said, “We are delighted to welcome Dr. Neeta Jain in our team and are confident that her expertise and calibre will prove to be a major contributor in the success of Crysta IVF. With her stellar work experience, we will able to improve effectiveness of our business operations and make Crysta IVF, the most preferred name for couples choosing IVF. We are hopeful to take the services of Crysta IVF across India and internationally in the near future.”
Talking about her new role, Dr. Neeta Jain, said, “Crysta IVF is amongst the leading companies working in the IVF space with a steady focus on delivering quality treatments at affordable rates and ensuring accessibility at the same time. Having a long-term experience in the industry, I understand the critical role that efficient operations play for an IVF company. Thus, my endeavor will be to bring an approach that will lead the company towards the growth trajectory.”